期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

弥漫大B细胞淋巴瘤预后相关因素研究进展 被引量：2

Progress of prognostic factors in diffuse large B-cell lymphoma
原文传递
导出
摘要 弥漫大B细胞淋巴瘤（DLBCL）是一种最常见的侵袭性非霍奇金B细胞淋巴瘤（B-NHL）,在临床表现和预后等方面具有显著的异质性,多种因素影响其预后.文章根据国内外研究进展,从临床特征及分子生物学特征两方面对影响DLBCL患者预后的因素进行综述. Diffuse large B-cell lymphoma （DLBCL） is one of the most common progressive B-cell non-Hodgkin lymphoma affected by varieties of factors, which is featured by strong heterogeneity in clinic and prognosis. This review discusses the prognostic factors affecting DLBCL patients in both clinical and molecular biology characteristics according to domestic and abroad research progress.
作者 王琳 万岁桂
机构地区 首都医科大学宣武医院血液科
出处 《白血病．淋巴瘤》 CAS 2017年第4期246-249,共4页 Journal of Leukemia & Lymphoma
关键词 淋巴瘤 大B-细胞 弥漫性 预后 Lymphoma, large B-cell, diffuse Prognosis
分类号 R733.1 [医药卫生—肿瘤]
  • 相关文献

参考文献8

二级参考文献115

  • 1周吉成.非霍奇金淋巴瘤治疗现状[J].广西医学,2005,27(10):1508-1509. 被引量：5
  • 2李宇红,何义富,王风华,林旭滨,夏忠军,孙晓非,林桐榆,黄慧强,张力,徐瑞华,姜文奇,管忠震.116例携带乙肝病毒的淋巴瘤患者化疗后发生肝功能损害的临床分析[J].癌症,2005,24(12):1507-1509. 被引量：24
  • 3Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of tumor of haematopoietic and lymphoid tissues. Lyon: IARC Press,2008:233-244.
  • 4Iqbal J, Neppalli VT, Wrigh G, et al. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. J Clin Oncol,2006, 24(6) : 961-968.
  • 5Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood ,2004,103 (1) : 275-282.
  • 6Choi WW, Weisenburger DD, Greiner TC, et al. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res,2009,15 ( 17 ) : 5494-5502.
  • 7Muris JJ, Mcijer C J, Vos W, et al. lmmunohistochemical profiling based on bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma. J Pathol,2006,208(5) :714-723.
  • 8Monni O, Joensuu H, Franssila K, et al. BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood, 1997, 90 ( 3 ) : 1168-1174.
  • 9Sun SC, Ley SC. New insights into NF-kappaB regulation and function. Trends Immunol,2008,29 ( 10 ) :469-478.
  • 10Pavan A, Spina M, Canzonieri V, et al. Recent prognostic factors in diffuse large B-cell lymphoma indicate NF-kB pathway as a target for new therapeutic strategies. Leuk Lymphoma, 2008,49 ( 11 ) : 2048-2058.

共引文献53

同被引文献4

引证文献2

二级引证文献13

白血病．淋巴瘤
2017年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部